2023 PARTNERS
Mission Bio
Innovation Partner
Mission Bio is a life sciences company that accelerates discoveries and cures for a wide range of diseases by equipping researchers with the tools they need to better measure, characterize, and predict our resistance and response to new therapies. Mission Bio’s multi-omics approach improves time-to-market for new therapeutics, including innovative cell and gene therapies that provide new pathways to health. The company's Tapestri Platform is being utilized by customers at leading research centers, pharmaceutical, and diagnostics companies worldwide. A Tapestri assay recently entered GMP qualification and validation, indicating that single-cell analysis is on its way to routine use in clinical trials to support the next wave of life-saving CGT treatments.
Samplix
Exhibition Partner
Samplix has developed unique microfluidics instruments to support key potency assays, including killer cell potential and cytokine secretion. Xdrop and Xdrop Sort enable high-throughput, sensitive, and accurate functional analysis with single-cell resolution by encapsulating living cells in highly stable double-emulsion droplets that act as microenvironments for incubation, guaranteeing rapid buildup of secretions or cell–cell interactions. Xdrop Sort also enables cell sorting based on fluorescence. Xdrop can change how you analyze cells.
Miltenyi Biotec
Exhibition Partner
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative technologies enable solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer. Miltenyi Biotec has more than 4,700 employees in 23 countries.
Accellix
Exhibition Partner
The Accellix Automated Cell Phenotyping Platform seamlessly integrates the capabilities of flow cytometry within the GMP manufacturing suite. By automating every strep from sample preparation to data acquisition and analysis, this platform excels in optimizing the intricate processes of incoming, in-process, and release quality control testing throughout the cell therapy manufacturing workflow. This empowers our valued cell therapy partners to fulfil their essential quality control requirements whilst propelling life changing therapies that benefit patients worldwide.
